omega-n-methylarginine has been researched along with MODS in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anzueto, A; Arneson, C; Bakker, J; Breen, D; Brockway, M; Donaldson, J; Grossman, S; Grove, G; Grover, R; Holzapfel, L; López, A; Lorente, JA; McLuckie, A; Silverman, MS; Steingrub, J; Takala, J; Willatts, S | 1 |
| Agarwal, N; Chalasani, S; Lentz, KE; Lomis, TJ; Lowenstein, CJ; McMillan, A; Rhoads, JE; Siffring, CW; Stauffer, KE; Ziegler, DW | 1 |
| Ruetten, H; Thiemermann, C; Vane, JR; Wu, CC | 1 |
| Buchman, TG; Cobb, JP; DeMeester, SL; Dunnigan, K; Hotchkiss, RS; Karl, IE; Qiu, Y | 1 |
| Acuña-Castroviejo, D; Crespo, E; Escames, G; Guerrero, JM; Macías, M; Martín, M; Pozo, D; Vives, F | 1 |
1 trial(s) available for omega-n-methylarginine and MODS
| Article | Year |
|---|---|
Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cause of Death; Critical Care; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Intensive Care Units; Male; Middle Aged; Multiple Organ Failure; Nitric Oxide Synthase; omega-N-Methylarginine; Reference Values; Risk Assessment; Severity of Illness Index; Shock, Septic; Survival Analysis; Treatment Outcome | 2004 |
4 other study(ies) available for omega-n-methylarginine and MODS
| Article | Year |
|---|---|
First place winner of the Conrad Jobst Award in the gold medal paper competition. Nitric oxide synthase inhibitors N-monomethylarginine and aminoguanidine prevent the progressive and severe hypotension associated with a rat model of pancreatitis.
Topics: Amylases; Animals; Arginine; Blood Pressure; Calcium; Clinical Protocols; Disease Models, Animal; Drug Evaluation, Preclinical; Fluid Therapy; Guanidines; Humans; Hypotension; Immunohistochemistry; Male; Multiple Organ Failure; Nitric Oxide; omega-N-Methylarginine; Pancreatitis; Premedication; Rats; Rats, Sprague-Dawley; Resuscitation; Severity of Illness Index | 1995 |
The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase.
Topics: Animals; Arginine; beta-Aminoethyl Isothiourea; Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Enzyme Induction; Enzyme Inhibitors; Kidney Diseases; Lipopolysaccharides; Male; Multiple Organ Failure; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Rats, Wistar | 1995 |
Nitric oxide inhibits stress-induced endothelial cell apoptosis.
Topics: Animals; Apoptosis; Arsenites; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; In Vitro Techniques; Lipopolysaccharides; Multiple Organ Failure; NF-kappa B; Nitric Oxide; omega-N-Methylarginine; Penicillamine; Prospective Studies; Sodium Compounds; Swine; Triazenes | 1998 |
Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide-induced multiple organ dysfunction syndrome in rats.
Topics: Animals; Drug Administration Schedule; Endotoxemia; Gene Expression Regulation, Enzymologic; Kidney; Lipid Peroxidation; Lipopolysaccharides; Liver; Lung; Male; Melatonin; Multiple Organ Failure; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; omega-N-Methylarginine; Rats; Rats, Wistar; RNA, Messenger; Time Factors; Transcription, Genetic | 1999 |